EichorEICHOR
Condition: De Novo Prostate Cancer Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: De Novo Prostate Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
Phase 2 · 2 location(s) · Case Comprehensive Cancer Center · NCT06150417Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05873192A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitor
Phase N/A · 1 location(s) · Bayer · NCT07406282Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer
Phase N/A · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07686016TERPS Trial for de Novo Oligometastic Prostate Cancer
Phase 2 · 10 location(s) · University of Maryland, Baltimore · NCT05223803Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local
Phase 2/Phase 3 · 20 location(s) · VA Office of Research and Development · NCT04787744Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
Phase 3 · 25 location(s) · UNICANCER · NCT06496581CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer
NA · 1 location(s) · RenJi Hospital · NCT06306612ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerabl
Phase 3 · 95 location(s) · UNICANCER · NCT04916613
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.